Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GFAP Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global GFAP Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Immunofluorescence
1.3.3 Western Blot
1.3.4 Immunohistochemistry Frozen
1.3.5 Immunohistochemistry Paraffin
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GFAP Antibody Market Perspective (2018-2029)
2.2 GFAP Antibody Growth Trends by Region
2.2.1 Global GFAP Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 GFAP Antibody Historic Market Size by Region (2018-2024)
2.2.3 GFAP Antibody Forecasted Market Size by Region (2024-2029)
2.3 GFAP Antibody Market Dynamics
2.3.1 GFAP Antibody Industry Trends
2.3.2 GFAP Antibody Market Drivers
2.3.3 GFAP Antibody Market Challenges
2.3.4 GFAP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GFAP Antibody Players by Revenue
3.1.1 Global Top GFAP Antibody Players by Revenue (2018-2024)
3.1.2 Global GFAP Antibody Revenue Market Share by Players (2018-2024)
3.2 Global GFAP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GFAP Antibody Revenue
3.4 Global GFAP Antibody Market Concentration Ratio
3.4.1 Global GFAP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GFAP Antibody Revenue in 2022
3.5 GFAP Antibody Key Players Head office and Area Served
3.6 Key Players GFAP Antibody Product Solution and Service
3.7 Date of Enter into GFAP Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GFAP Antibody Breakdown Data by Type
4.1 Global GFAP Antibody Historic Market Size by Type (2018-2024)
4.2 Global GFAP Antibody Forecasted Market Size by Type (2024-2029)
5 GFAP Antibody Breakdown Data by Application
5.1 Global GFAP Antibody Historic Market Size by Application (2018-2024)
5.2 Global GFAP Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America GFAP Antibody Market Size (2018-2029)
6.2 North America GFAP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America GFAP Antibody Market Size by Country (2018-2024)
6.4 North America GFAP Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GFAP Antibody Market Size (2018-2029)
7.2 Europe GFAP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe GFAP Antibody Market Size by Country (2018-2024)
7.4 Europe GFAP Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GFAP Antibody Market Size (2018-2029)
8.2 Asia-Pacific GFAP Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific GFAP Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific GFAP Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GFAP Antibody Market Size (2018-2029)
9.2 Latin America GFAP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America GFAP Antibody Market Size by Country (2018-2024)
9.4 Latin America GFAP Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GFAP Antibody Market Size (2018-2029)
10.2 Middle East & Africa GFAP Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa GFAP Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa GFAP Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aviva Systems Biology
11.1.1 Aviva Systems Biology Company Detail
11.1.2 Aviva Systems Biology Business Overview
11.1.3 Aviva Systems Biology GFAP Antibody Introduction
11.1.4 Aviva Systems Biology Revenue in GFAP Antibody Business (2018-2024)
11.1.5 Aviva Systems Biology Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck GFAP Antibody Introduction
11.2.4 Merck Revenue in GFAP Antibody Business (2018-2024)
11.2.5 Merck Recent Development
11.3 FineTest
11.3.1 FineTest Company Detail
11.3.2 FineTest Business Overview
11.3.3 FineTest GFAP Antibody Introduction
11.3.4 FineTest Revenue in GFAP Antibody Business (2018-2024)
11.3.5 FineTest Recent Development
11.4 Santa Cruz Biotechnology
11.4.1 Santa Cruz Biotechnology Company Detail
11.4.2 Santa Cruz Biotechnology Business Overview
11.4.3 Santa Cruz Biotechnology GFAP Antibody Introduction
11.4.4 Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2018-2024)
11.4.5 Santa Cruz Biotechnology Recent Development
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Detail
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec GFAP Antibody Introduction
11.5.4 Miltenyi Biotec Revenue in GFAP Antibody Business (2018-2024)
11.5.5 Miltenyi Biotec Recent Development
11.6 Sino Biological
11.6.1 Sino Biological Company Detail
11.6.2 Sino Biological Business Overview
11.6.3 Sino Biological GFAP Antibody Introduction
11.6.4 Sino Biological Revenue in GFAP Antibody Business (2018-2024)
11.6.5 Sino Biological Recent Development
11.7 Enzo Life Sciences
11.7.1 Enzo Life Sciences Company Detail
11.7.2 Enzo Life Sciences Business Overview
11.7.3 Enzo Life Sciences GFAP Antibody Introduction
11.7.4 Enzo Life Sciences Revenue in GFAP Antibody Business (2018-2024)
11.7.5 Enzo Life Sciences Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Detail
11.8.2 Proteintech Business Overview
11.8.3 Proteintech GFAP Antibody Introduction
11.8.4 Proteintech Revenue in GFAP Antibody Business (2018-2024)
11.8.5 Proteintech Recent Development
11.9 Atlas Antibodies
11.9.1 Atlas Antibodies Company Detail
11.9.2 Atlas Antibodies Business Overview
11.9.3 Atlas Antibodies GFAP Antibody Introduction
11.9.4 Atlas Antibodies Revenue in GFAP Antibody Business (2018-2024)
11.9.5 Atlas Antibodies Recent Development
11.10 GeneTex
11.10.1 GeneTex Company Detail
11.10.2 GeneTex Business Overview
11.10.3 GeneTex GFAP Antibody Introduction
11.10.4 GeneTex Revenue in GFAP Antibody Business (2018-2024)
11.10.5 GeneTex Recent Development
11.11 Synaptic Systems
11.11.1 Synaptic Systems Company Detail
11.11.2 Synaptic Systems Business Overview
11.11.3 Synaptic Systems GFAP Antibody Introduction
11.11.4 Synaptic Systems Revenue in GFAP Antibody Business (2018-2024)
11.11.5 Synaptic Systems Recent Development
11.12 Hytest
11.12.1 Hytest Company Detail
11.12.2 Hytest Business Overview
11.12.3 Hytest GFAP Antibody Introduction
11.12.4 Hytest Revenue in GFAP Antibody Business (2018-2024)
11.12.5 Hytest Recent Development
11.13 ProSci
11.13.1 ProSci Company Detail
11.13.2 ProSci Business Overview
11.13.3 ProSci GFAP Antibody Introduction
11.13.4 ProSci Revenue in GFAP Antibody Business (2018-2024)
11.13.5 ProSci Recent Development
11.14 EnCor Biotechnology
11.14.1 EnCor Biotechnology Company Detail
11.14.2 EnCor Biotechnology Business Overview
11.14.3 EnCor Biotechnology GFAP Antibody Introduction
11.14.4 EnCor Biotechnology Revenue in GFAP Antibody Business (2018-2024)
11.14.5 EnCor Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global GFAP Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global GFAP Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global GFAP Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global GFAP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global GFAP Antibody Market Share by Region (2018-2024)
Table 8. Global GFAP Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global GFAP Antibody Market Share by Region (2024-2029)
Table 10. GFAP Antibody Market Trends
Table 11. GFAP Antibody Market Drivers
Table 12. GFAP Antibody Market Challenges
Table 13. GFAP Antibody Market Restraints
Table 14. Global GFAP Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global GFAP Antibody Market Share by Players (2018-2024)
Table 16. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2022)
Table 17. Ranking of Global Top GFAP Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by GFAP Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players GFAP Antibody Product Solution and Service
Table 21. Date of Enter into GFAP Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GFAP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global GFAP Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global GFAP Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global GFAP Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global GFAP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global GFAP Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global GFAP Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global GFAP Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America GFAP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America GFAP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe GFAP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe GFAP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific GFAP Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific GFAP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific GFAP Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America GFAP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America GFAP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa GFAP Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa GFAP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa GFAP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. Aviva Systems Biology Company Detail
Table 47. Aviva Systems Biology Business Overview
Table 48. Aviva Systems Biology GFAP Antibody Product
Table 49. Aviva Systems Biology Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 50. Aviva Systems Biology Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck GFAP Antibody Product
Table 54. Merck Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. FineTest Company Detail
Table 57. FineTest Business Overview
Table 58. FineTest GFAP Antibody Product
Table 59. FineTest Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 60. FineTest Recent Development
Table 61. Santa Cruz Biotechnology Company Detail
Table 62. Santa Cruz Biotechnology Business Overview
Table 63. Santa Cruz Biotechnology GFAP Antibody Product
Table 64. Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 65. Santa Cruz Biotechnology Recent Development
Table 66. Miltenyi Biotec Company Detail
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec GFAP Antibody Product
Table 69. Miltenyi Biotec Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Sino Biological Company Detail
Table 72. Sino Biological Business Overview
Table 73. Sino Biological GFAP Antibody Product
Table 74. Sino Biological Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 75. Sino Biological Recent Development
Table 76. Enzo Life Sciences Company Detail
Table 77. Enzo Life Sciences Business Overview
Table 78. Enzo Life Sciences GFAP Antibody Product
Table 79. Enzo Life Sciences Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 80. Enzo Life Sciences Recent Development
Table 81. Proteintech Company Detail
Table 82. Proteintech Business Overview
Table 83. Proteintech GFAP Antibody Product
Table 84. Proteintech Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 85. Proteintech Recent Development
Table 86. Atlas Antibodies Company Detail
Table 87. Atlas Antibodies Business Overview
Table 88. Atlas Antibodies GFAP Antibody Product
Table 89. Atlas Antibodies Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 90. Atlas Antibodies Recent Development
Table 91. GeneTex Company Detail
Table 92. GeneTex Business Overview
Table 93. GeneTex GFAP Antibody Product
Table 94. GeneTex Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 95. GeneTex Recent Development
Table 96. Synaptic Systems Company Detail
Table 97. Synaptic Systems Business Overview
Table 98. Synaptic Systems GFAP Antibody Product
Table 99. Synaptic Systems Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 100. Synaptic Systems Recent Development
Table 101. Hytest Company Detail
Table 102. Hytest Business Overview
Table 103. Hytest GFAP Antibody Product
Table 104. Hytest Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 105. Hytest Recent Development
Table 106. ProSci Company Detail
Table 107. ProSci Business Overview
Table 108. ProSci GFAP Antibody Product
Table 109. ProSci Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 110. ProSci Recent Development
Table 111. EnCor Biotechnology Company Detail
Table 112. EnCor Biotechnology Business Overview
Table 113. EnCor Biotechnology GFAP Antibody Product
Table 114. EnCor Biotechnology Revenue in GFAP Antibody Business (2018-2024) & (US$ Million)
Table 115. EnCor Biotechnology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GFAP Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global GFAP Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global GFAP Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global GFAP Antibody Market Share by Application: 2022 VS 2029
Figure 7. Immunofluorescence Case Studies
Figure 8. Western Blot Case Studies
Figure 9. Immunohistochemistry Frozen Case Studies
Figure 10. Immunohistochemistry Paraffin Case Studies
Figure 11. Others Case Studies
Figure 12. GFAP Antibody Report Years Considered
Figure 13. Global GFAP Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global GFAP Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GFAP Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global GFAP Antibody Market Share by Players in 2022
Figure 17. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by GFAP Antibody Revenue in 2022
Figure 19. North America GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America GFAP Antibody Market Share by Country (2018-2029)
Figure 21. United States GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe GFAP Antibody Market Share by Country (2018-2029)
Figure 25. Germany GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific GFAP Antibody Market Share by Region (2018-2029)
Figure 33. China GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America GFAP Antibody Market Share by Country (2018-2029)
Figure 41. Mexico GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa GFAP Antibody Market Share by Country (2018-2029)
Figure 45. Turkey GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia GFAP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Aviva Systems Biology Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 48. Merck Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 49. FineTest Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 50. Santa Cruz Biotechnology Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 51. Miltenyi Biotec Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 52. Sino Biological Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 53. Enzo Life Sciences Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 54. Proteintech Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 55. Atlas Antibodies Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 56. GeneTex Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 57. Synaptic Systems Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 58. Hytest Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 59. ProSci Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 60. EnCor Biotechnology Revenue Growth Rate in GFAP Antibody Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed